Vitiligo: A comprehensive overview : Part II: Treatment options and approach to treatment - 13/08/11
Correspondence to: Vesna Petronic-Rosic, MD, MSc, Associate Professor and Clinic Director, The University of Chicago Section of Dermatology, 5841 S Maryland Ave, MC 5067, Chicago, IL 60637.Abstract |
Vitiligo is a common skin disorder that results in depigmentation. With the appropriate management, many patients can minimize disease progression, attain repigmentation, and achieve cosmetically pleasing results. There are numerous medical and surgical treatments aimed at repigmentation; therapies for depigmentation are available for patients with recalcitrant or advanced disease. The use of cosmetics at all stages of treatment may be vital to the patient's quality of life. Understanding all the available options helps choose the appropriate treatment plan and tailor it to your patient. Part II of this two-part series on vitiligo discusses the indications for, evidence behind, and adverse effects associated with many of the therapies used for vitiligo. Both conventional medical and surgical options are discussed in addition to several alternative and promising new therapies.
Le texte complet de cet article est disponible en PDF.Key words : antioxidants, autoimmune, autologous melanocyte suspension graft, biologic agents, camouflage, corticosteroids, chemophototherapy, depigmentation, depigmented, hypopigmentation, hypopigmented, laser, leukoderma, macule, melanocyte, melanosome, phototherapy, psychotherapy, punch graft, split thickness skin graft, suction blister graft, topical calcineurin inhibitors, vitamin D3 analogs, vitiligo
Plan
| Drs Felsten and Alikhan contributed equally to this manuscript. |
|
| Funding sources: None. |
|
| Reprints not available from the authors. |
Vol 65 - N° 3
P. 493-514 - septembre 2011 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?